Okla. Admin. Code § 475:30-1-13

Current through Vol. 42, No. 4, November 1, 2024

Section 475:30-1-13 - Requirements of prescriptions for controlled dangerous substances listed in Schedule V

(a) A pharmacist of a registered or otherwise authorized pharmacy may dispense directly a controlled dangerous substance listed in Schedule V pursuant to a prescription as required for controlled dangerous substances listed in Schedules III and IV. A prescription for a controlled dangerous substance listed in Schedule V may be refilled only the number of times expressly authorized by the prescribing registered individual practitioner on the face of the prescription, and such prescription may not be refilled more than six (6) months after the date of issuance. If no such authorization is given, the prescription may not be refilled. A pharmacist dispensing such substance pursuant to a prescription shall label the substance and file the prescription.

(b) A registered individual practitioner may administer or dispense directly a controlled dangerous substance listed in Schedule V, in the course of his/her professional practice, without a prescription.

(c) An institutional physician limited in practice by the individual's appropriate State of Oklahoma professional licensing board, other than those registered as fee-exempt with the Oklahoma State Bureau of Narcotics and Dangerous Drugs Control, may administer or dispense directly (but not prescribe) a controlled dangerous substance listed in Schedule V only pursuant to a written prescription signed by the "Limited Institutional Practitioner's" supervising chief medical practitioner, or pursuant to an electronic prescription in compliance with the terms of 21 CFR §§ 1311 et. seq, or pursuant to an order for medication made by a "Limited Institutional Practitioner's" supervising chief medical practitioner which is dispensed for immediate administration to the ultimate user.

Okla. Admin. Code § 475:30-1-13

Amended at 12 Ok Reg 2847, eff 7-15-95

Amended by Oklahoma Register, Volume 41, Issue 21, July 15, 2024, eff. 8/4/2024